These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14558982)

  • 21. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
    Smebye ML; Iversen EK; Høieggen A; Flaa A; Os I; Kjeldsen SE; Olsen MH; Chattopadhyay A; Hille DA; Lyle PA; Devereux RB; Dahlöf B
    Am J Cardiol; 2007 Sep; 100(5):855-9. PubMed ID: 17719333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial.
    Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH;
    S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M; Junren Z; Maxwell T; Rodriguez A; Gamboa R; Gomez-Fernandez P; Ortega-Gonzalez G; Matadamas N; Rodriguez F; Dass B; Kyle C; Clarysse L; Bryce A; Moreno-Heredia E; Germano G; Gilles L; Smith RD; Sanderson JE;
    Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
    Os I; Gudmundsdottir H; Kjeldsen SE; Oparil S
    Diabetes Obes Metab; 2006 Jul; 8(4):381-7. PubMed ID: 16776744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits of antihypertensive drug treatment in elderly patients with isolated systolic hypertension.
    Wang JG; Staessen JA
    Neth J Med; 2001 Jun; 58(6):248-54. PubMed ID: 11395222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical significance of systolic hypertension.
    Cushman WC
    Am J Hypertens; 1998 Nov; 11(11 Pt 2):182S-185S. PubMed ID: 9833877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Losartan: a review of its use, with special focus on elderly patients.
    Simpson KL; McClellan KJ
    Drugs Aging; 2000 Mar; 16(3):227-50. PubMed ID: 10803861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal drug treatment of systolic hypertension in the elderly.
    Pannarale G
    Drugs Aging; 2008; 25(1):1-8. PubMed ID: 18184024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of treating hypertension in the elderly: a short commentary on current issues.
    Weber MA
    Am J Geriatr Cardiol; 2003; 12(1):14-8. PubMed ID: 12502910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?
    Zanchetti A; Ruilope LM
    J Hypertens; 2002 Nov; 20(11):2099-110. PubMed ID: 12409940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated Systolic Hypertension: An Update After SPRINT.
    Bavishi C; Goel S; Messerli FH
    Am J Med; 2016 Dec; 129(12):1251-1258. PubMed ID: 27639873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ASCOT trial: clarifying the role of ACE inhibition in the reduction of cardiovascular events in patients with hypertension.
    Meurin P
    Am J Cardiovasc Drugs; 2006; 6(5):327-34. PubMed ID: 17083267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Lyle PA
    Expert Opin Pharmacother; 2004 Nov; 5(11):2311-20. PubMed ID: 15500378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial.
    Gerdts E; Wachtell K; Omvik P; Otterstad JE; Oikarinen L; Boman K; Dahlöf B; Devereux RB
    Hypertension; 2007 Feb; 49(2):311-6. PubMed ID: 17178978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
    Devereux RB; Dahlöf B; Kjeldsen SE; Julius S; Aurup P; Beevers G; Edelman JM; de Faire U; Fyhrquist F; Helle Berg S; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Snapinn S; Wedel H;
    Ann Intern Med; 2003 Aug; 139(3):169-77. PubMed ID: 12899584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved outcomes with antihypertensive medication in the elderly with isolated systolic hypertension.
    Wang JG; Staessen JA
    Drugs Aging; 2001; 18(5):345-53. PubMed ID: 11392443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.